RVTY
Revvity Inc.
NYSE: RVTY · HEALTHCARE · DIAGNOSTICS & RESEARCH
$99.09
+7.36% today
Updated 2026-05-06
Market cap
$9.69B
P/E ratio
42.08
P/S ratio
3.39x
EPS (TTM)
$2.06
Dividend yield
0.32%
52W range
$81 – $118
Volume
1.1M
Revvity Inc. (RVTY) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.55B | $1.79B | $1.96B | $1.55B | $1.70B | $1.92B | $2.12B | $2.17B | $2.24B | $2.10B | $2.12B | $2.26B | $2.78B | $2.88B | $3.78B | $3.83B | $3.31B | $2.75B | $2.76B | $2.86B |
| Revenue growth (YoY) | — | +15.6% | +9.7% | -20.9% | +9.9% | +12.7% | +10.1% | +2.4% | +3.3% | -5.9% | +0.5% | +6.7% | +23.1% | +3.8% | +31.2% | +1.2% | -13.5% | -16.9% | +0.2% | +3.7% |
| Cost of revenue | $922.89M | $1.07B | $1.12B | $851.78M | $963.91M | $1.10B | $1.19B | $1.23B | $1.27B | $1.17B | $1.14B | $1.23B | $1.53B | $1.59B | $1.79B | $1.55B | $1.55B | $1.43B | $1.43B | $1.34B |
| Gross profit | $623.47M | $715.14M | $835.07M | $698.98M | $740.43M | $823.98M | $923.81M | $939.97M | $971.01M | $930.03M | $972.25M | $1.03B | $1.25B | $1.29B | $1.99B | $2.28B | $1.76B | $1.32B | $1.32B | $1.52B |
| Gross margin | 40.3% | 40.0% | 42.6% | 45.1% | 43.4% | 42.9% | 43.7% | 43.4% | 43.4% | 44.2% | 46.0% | 45.6% | 45.0% | 44.8% | 52.6% | 59.6% | 53.2% | 48.1% | 48.0% | 53.1% |
| R&D | $98.12M | $109.92M | $108.94M | $90.78M | $93.81M | $115.12M | $132.14M | $132.52M | $120.54M | $112.04M | $123.78M | $139.16M | $186.10M | $189.34M | $205.39M | $200.34M | $221.62M | $216.58M | $196.84M | $215.84M |
| SG&A | — | — | — | — | — | — | — | — | — | — | — | — | — | $815.32M | $917.89M | $1.23B | $1.03B | $1.02B | $994.07M | $991.89M |
| Operating income | $151.50M | $174.65M | $201.31M | $140.09M | $172.76M | $117.94M | $200.78M | $258.76M | $230.49M | $266.79M | $305.67M | $304.63M | $370.97M | $405.48M | $1.02B | $1.34B | $781.12M | $399.49M | $410.52M | $356.63M |
| Operating margin | 9.8% | 9.8% | 10.3% | 9.0% | 10.1% | 6.1% | 9.5% | 11.9% | 10.3% | 12.7% | 14.4% | 13.5% | 13.4% | 14.1% | 27.0% | 35.0% | 23.6% | 14.5% | 14.9% | 12.5% |
| EBITDA | $229.08M | $244.61M | $262.65M | $200.91M | $267.04M | $200.06M | $223.24M | $331.73M | $322.61M | $352.17M | $385.57M | $445.66M | $505.25M | $514.79M | $1.20B | $1.62B | $1.18B | $713.56M | $840.25M | $662.72M |
| EBITDA margin | 14.8% | 13.7% | 13.4% | 13.0% | 15.7% | 10.4% | 10.6% | 15.3% | 14.4% | 16.7% | 18.2% | 19.7% | 18.2% | 17.9% | 31.8% | 42.2% | 35.7% | 25.9% | 30.5% | 23.2% |
| EBIT | $159.89M | $166.61M | $174.03M | $120.14M | $177.88M | $89.14M | $96.37M | $203.26M | $205.87M | $246.80M | $285.60M | $340.66M | $324.66M | $300.77M | $956.08M | $1.31B | $755.79M | $281.79M | $412.40M | $360.46M |
| Interest expense | $1.23M | $41.70M | $82.14M | $17.16M | $15.89M | $24.78M | $45.79M | $49.92M | $36.27M | $38.00M | $41.53M | $43.94M | $66.98M | $63.63M | $49.71M | $102.13M | $103.95M | $98.81M | $96.28M | $92.19M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $117.15M | $132.92M | $128.41M | $85.60M | $383.92M | $1.17M | $68.44M | $167.92M | $158.04M | $212.45M | $233.68M | $113.02M | $238.79M | $227.56M | $728.10M | $943.16M | $569.18M | $-118.38M | $295.83M | $241.68M |
| Net income growth (YoY) | — | +13.5% | -3.4% | -33.3% | +348.5% | -99.7% | +5739.7% | +145.4% | -5.9% | +34.4% | +10.0% | -51.6% | +111.3% | -4.7% | +220.0% | +29.5% | -39.7% | -120.8% | +349.9% | -18.3% |
| Profit margin | 7.6% | 7.4% | 6.6% | 5.5% | 22.5% | 0.1% | 3.2% | 7.8% | 7.1% | 10.1% | 11.0% | 5.0% | 8.6% | 7.9% | 19.2% | 24.6% | 17.2% | -4.3% | 10.7% | 8.5% |